WHO Expert Committee on Biological Standardization [meeting held in Geneva from 12 to 18 November 1985] : thirty-sixth report.
Material type:
TextSeries: World Health Organization technical report series ; no. 745Publication details: Geneva : World Health Organization, 1987.Description: 149 pISBN: - 9241207450
- QW 800
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Books
|
WHO HQ READING-RM | HQ SERIAL (Browse shelf(Opens below)) | 1 | Available | 00004709 | ||
|
Books
|
WHO HQ BORROWABLE-COLL-STACKS | QW 800 87WH (Browse shelf(Opens below)) | 2 | Withdrawn | 00004710 | ||
|
Books
|
WHO HQ ONLINE-IRIS | QW 800 87WH (Browse shelf(Opens below)) | 3 | Available | O9241207450 | ||
|
Books
|
WHO HQ ONLINE-IRIS | HQ SERIAL RUS (Browse shelf(Opens below)) | 1 | Available | O9241207450RUS |
Browsing WHO HQ shelves, Shelving location: ONLINE-IRIS Close shelf browser (Hides shelf browser)
| HQ SERIAL RUS Rapid laboratory techniques for the diagnosis of viral infections : | HQ SERIAL RUS The promotion and development of traditional medicine : | HQ SERIAL RUS Treatment of haemoglobinopathies and allied disorders : | HQ SERIAL RUS WHO Expert Committee on Biological Standardization [meeting held in Geneva from 12 to 18 November 1985] : | HQ SERIAL RUS Viral hepatitis : | HQ SERIAL RUS Safe use of pesticides : | HQ SERIAL RUS Schistosomiasis control : |
Russian version of nos. 728-749 bound together (barcode no. 00073792).
Announces changes in the status or development of 34 biologicals. The report also presents full details on revised requirements for the manufacturing and national control of tuberculins, dried BCG vaccine, and continuous cell lines, followed by amended requirements for inactivated poliomyelitis vaccine and an addendum to the requirements for antimicrobic susceptibility. A concluding section presents data documenting the history of the production of the WHO primary seed of 17D yellow fever virus to be used in the production of vaccine. As with previous reports from this committee, the present work will serve as both an indispensable reference for manufacturers and control authorities and an integral part of WHOs efforts to assure the production of safe, reliable, and potent biologicals.
eng fre rus spa.
WHODOC
WHO monograph
4
There are no comments on this title.